Damiano Baroncini

7PUBLICATIONS
17CO-AUTHORS
Regenerative medicine (incl. stem cells)Infant and child healthCancer therapy (excl. chemotherapy and radiation therapy)Obstetrics and gynaecologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 16, 2022
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register.

Pietro Iaffaldano, Giuseppe Lucisano, Tommaso Guerra

|Jul 05, 2022
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study.

Damiano Baroncini, Angelo Ghezzi, Clara Guaschino

|Apr 15, 2021
Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy.

Elisabetta Signoriello, Giacomo Lus, Simona Bonavita

|Jun 14, 2019
Impact of natural menopause on multiple sclerosis: a multicentre study.

Damiano Baroncini, Pietro Osvaldo Annovazzi, Nicola De Rossi

|Jul 26, 2018
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study.

Francesco Saccà, Roberta Lanzillo, Alessio Signori

|Jan 25, 2018
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study.

Damiano Baroncini, Mauro Zaffaroni, Lucia Moiola

Pageof 2

Frequent Collaborators

2 joint publications

Pietro Iaffaldano

2 joint publications

Giorgia Teresa Maniscalco

2 joint publications

Antonio Carotenuto

1 joint publications

Giulia Mallucci